Profile data is unavailable for this security.
About the company
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
- Revenue in USD (TTM)57.57m
- Net income in USD-278.61m
- Incorporated2020
- Employees999.00
- LocationCureVac NVFriedrich-Miescher-Str. 15TUEBINGEN 72076GermanyDEU
- Phone+49 707198830
- Fax+49 707 198831101
- Websitehttps://www.curevac.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IGM Biosciences Inc | 2.13m | -246.42m | 558.87m | 224.00 | -- | 2.74 | -- | 262.38 | -4.81 | -4.81 | 0.0407 | 3.46 | 0.0046 | -- | -- | 9,508.93 | -52.60 | -44.66 | -58.00 | -48.20 | -- | -- | -11,568.83 | -23,668.96 | -- | -- | 0.00 | -- | 99.25 | -- | -11.45 | -- | 73.48 | -- |
| Arrivent Biopharma Inc | 0.00 | -69.33m | 559.01m | 40.00 | -- | -- | -- | -- | -2.17 | -2.17 | 0.00 | 4.73 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -87.86 | -- | -- | -- |
| Korro Bio Inc | 0.00 | -81.17m | 565.54m | 101.00 | -- | 2.88 | -- | -- | -68.38 | -68.38 | 0.00 | 21.20 | 0.00 | -- | -- | 0.00 | -47.34 | -31.55 | -53.69 | -36.48 | -- | -- | -- | -365.87 | -- | -- | 0.00 | -- | -- | -- | 0.5001 | -- | 78.21 | -- |
| SNDL Inc | 661.67m | -122.38m | 578.29m | 2.52k | -- | 0.6612 | -- | 0.874 | -0.4698 | -0.4825 | 2.55 | 3.36 | 0.5995 | 5.29 | 36.58 | 262,986.00 | -11.34 | -24.44 | -12.28 | -27.94 | 24.17 | 22.49 | -18.92 | -62.17 | 2.69 | -9.29 | 0.1196 | -- | 27.63 | -- | 49.83 | -- | -- | -- |
| Compass Pathways PLC (ADR) | 0.00 | -118.46m | 579.54m | 186.00 | -- | 2.33 | -- | -- | -2.39 | -2.39 | 0.00 | 3.64 | 0.00 | -- | -- | 0.00 | -50.06 | -40.85 | -54.08 | -44.48 | -- | -- | -- | -- | -- | -- | 0.113 | -- | -- | -- | -29.46 | -- | -12.68 | -- |
| Cabaletta Bio Inc | 0.00 | -67.68m | 580.85m | 101.00 | -- | 2.51 | -- | -- | -1.65 | -1.65 | 0.00 | 4.94 | 0.00 | -- | -- | 0.00 | -36.52 | -33.76 | -39.22 | -35.68 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -27.75 | -- | -- | -- |
| Olema Pharmaceuticals Inc | 0.00 | -96.66m | 581.51m | 74.00 | -- | 2.25 | -- | -- | -2.16 | -2.16 | 0.00 | 4.62 | 0.00 | -- | -- | 0.00 | -39.24 | -30.06 | -42.54 | -31.40 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.76 | -- | -- | -- |
| Absci Corp | 5.72m | -110.57m | 586.90m | 155.00 | -- | 2.74 | -- | 102.64 | -1.20 | -1.20 | 0.0621 | 1.89 | 0.0212 | -- | 3.06 | 36,890.32 | -41.08 | -- | -46.22 | -- | -- | -- | -1,933.65 | -- | -- | -93.25 | 0.0467 | -- | -0.5046 | -- | -5.40 | -- | -- | -- |
| CureVac BV | 57.57m | -278.61m | 593.40m | 999.00 | -- | 1.07 | -- | 10.31 | -1.26 | -1.26 | 0.2614 | 2.47 | 0.0652 | 5.10 | 4.12 | 57,627.32 | -31.56 | -27.93 | -39.84 | -35.70 | -131.34 | -91.31 | -483.96 | -395.90 | 2.43 | -- | 0.0749 | -- | -20.26 | 33.10 | -4.47 | -- | 30.25 | -- |
| Lyell Immunopharma Inc | 130.00k | -234.63m | 594.00m | 224.00 | -- | 0.9035 | -- | 4,569.25 | -0.9353 | -0.9353 | 0.0005 | 2.58 | 0.0002 | -- | -- | 580.36 | -27.81 | -- | -29.04 | -- | -- | -- | -180,486.20 | -- | -- | -- | 0.00 | -- | -99.85 | -- | -28.13 | -- | -- | -- |
| Aerovate Therapeutics Inc | 0.00 | -75.52m | 598.89m | 51.00 | -- | 5.29 | -- | -- | -2.87 | -2.87 | 0.00 | 3.94 | 0.00 | -- | -- | 0.00 | -57.49 | -- | -63.65 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -46.61 | -- | -- | -- |
| Stoke Therapeutics Inc | 8.78m | -104.70m | 602.48m | 110.00 | -- | 3.33 | -- | 68.61 | -2.38 | -2.38 | 0.1996 | 3.47 | 0.0363 | -- | 26.94 | 79,827.27 | -43.23 | -31.62 | -49.60 | -33.92 | -- | -- | -1,192.34 | -1,775.50 | -- | -- | 0.00 | -- | -29.22 | -- | -3.59 | -- | 11.56 | -- |
| Castle Biosciences Inc | 219.79m | -57.47m | 607.47m | 610.00 | -- | 1.54 | -- | 2.76 | -2.15 | -2.15 | 8.20 | 14.27 | 0.488 | 7.55 | 7.12 | 360,308.20 | -12.76 | -9.43 | -14.07 | -10.17 | 79.53 | 80.58 | -26.15 | -28.46 | 6.04 | -- | 0.0003 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
| Zymeworks Inc | 76.01m | -118.67m | 618.18m | 272.00 | -- | 1.33 | -- | 8.13 | -1.74 | -1.74 | 1.10 | 6.57 | 0.1236 | -- | 2.88 | 279,455.90 | -19.30 | -22.58 | -22.01 | -26.90 | -- | -- | -156.13 | -91.17 | -- | -- | 0.0003 | -- | -81.57 | 7.47 | -195.44 | -- | 3.58 | -- |
| GH Research PLC | 0.00 | -35.59m | 621.74m | 49.00 | -- | 2.84 | -- | -- | -0.6841 | -0.6841 | 0.00 | 4.21 | 0.00 | -- | -- | 0.00 | -14.81 | -- | -15.16 | -- | -- | -- | -- | -- | -- | -- | 0.0044 | -- | -- | -- | -58.47 | -- | -- | -- |
Data as of May 02 2024. Currency figures normalised to CureVac NV's reporting currency: US Dollar USD
7.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| RA Capital Management LPas of 31 Dec 2023 | 2.74m | 1.23% |
| Millennium Management LLCas of 31 Dec 2023 | 2.73m | 1.22% |
| T. Rowe Price Associates, Inc. (Investment Management)as of 31 Dec 2023 | 2.32m | 1.04% |
| Camber Capital Management LPas of 31 Dec 2023 | 1.75m | 0.78% |
| Alyeska Investment Group LPas of 31 Dec 2023 | 1.63m | 0.73% |
| Bill & Melinda Gates Foundation Trust (Investment Management)as of 31 Dec 2023 | 1.63m | 0.73% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 848.01k | 0.38% |
| Walleye Capital LLCas of 31 Dec 2023 | 793.35k | 0.35% |
| BlackRock Advisors LLCas of 31 Dec 2023 | 762.03k | 0.34% |
| Citadel Advisors LLCas of 31 Dec 2023 | 625.00k | 0.28% |
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
